Humana Inc (HUM · NYSE)

HUM · MARKET VIEW

Market view · as of Aug 24, 2026

Revenue (TTM)
$145.68B
+26.2% YoY
Gross margin
13.7%
EPS (latest q)
$7.61
vs $6.22 est · beat
52-wk position
87.6%
-7.5% vs 52w high · -2.7% 1mo

Price (last ~year)

Humana Inc. (HUM) posted a 26.2% year-over-year revenue increase to $145.68 billion TTM, having exceeded earnings estimates in each of the last four quarters. As of June 30, 2026, the company held $14.25 billion in total debt against $6.89 billion in cash, with a negative free cash flow of $558.0 million for the period. The stock, which holds a $45.50 billion market capitalization and a 35.84 P/E ratio, attracted new institutional positions from firms including the Bank of New York Mellon and the Bank of Nova Scotia during the second quarter.

Valuation

Market cap
$45.50B
P/E
35.84
PEG
2.146
P/B
2.368
P/S
0.312
Beta
0.74
Analyst target
$416.43

Quality & returns

Gross margin
13.7%
Operating margin
3.5%
Profit margin
0.9%
ROE
6.9%
ROA
3.9%

Price movement

Last
$378.88
1-month
-2.7%
3-month
+24.0%
RSI (14)
52
vs SMA200
+39.7%
52-wk position
87.6% -7.5% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$40.87B$1.36B$693.0M$1.31B
2026-03-31$39.65B$1.58B$1.19B$1.97B
2025-12-31$32.52B$-1.02B$-796.0M$-685.0M
2025-09-30$32.65B$108.0M$195.0M$480.0M

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots